The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Nkanka, Michael
    Director born in May 1961
    Individual (4 offsprings)
    Officer
    2022-01-06 ~ now
    OF - Director → CIF 0
    Mr Michael Nkanka
    Born in September 2022
    Individual (4 offsprings)
    Person with significant control
    2022-09-15 ~ now
    PE - Ownership of shares – 75% or more with control over the trustees of a trust → CIF 0
Ceased 6
  • 1
    Chinakwe, Christopher Okwufulueze
    Company Director born in September 1970
    Individual (2 offsprings)
    Officer
    2021-11-15 ~ 2022-04-01
    OF - Director → CIF 0
    Chinakwe, Christopher Okwufulueze
    Individual (2 offsprings)
    Officer
    2021-11-15 ~ 2022-04-01
    OF - Secretary → CIF 0
    Mr Christopher Okwufulueze Chinakwe
    Born in September 1970
    Individual (2 offsprings)
    Person with significant control
    2021-11-15 ~ 2022-04-01
    PE - Ownership of shares – 75% or more → CIF 0
  • 2
    Moosa, Ibrahim Tayub
    Company Director born in August 1981
    Individual (3 offsprings)
    Officer
    2019-08-16 ~ 2020-05-01
    OF - Director → CIF 0
  • 3
    Nkanka, Michael
    Director born in May 1961
    Individual (4 offsprings)
    Officer
    2019-01-14 ~ 2021-11-15
    OF - Director → CIF 0
    Nkanka, Michael
    Individual (4 offsprings)
    Officer
    2019-01-14 ~ 2021-11-15
    OF - Secretary → CIF 0
    Mr Michael Nkanka
    Born in May 1961
    Individual (4 offsprings)
    Person with significant control
    2019-01-14 ~ 2021-11-15
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 4
    Hussain, Muhammad Sakhawat
    Company Director born in September 1985
    Individual (1 offspring)
    Officer
    2019-08-16 ~ 2020-05-01
    OF - Director → CIF 0
    2020-03-01 ~ 2021-11-15
    OF - Director → CIF 0
  • 5
    Nduka, Nnado Collins
    Director born in April 1984
    Individual (1 offspring)
    Officer
    2021-06-22 ~ 2021-11-08
    OF - Director → CIF 0
  • 6
    Haseeb, Abdul
    Company Director born in September 1985
    Individual
    Officer
    2019-08-01 ~ 2019-08-01
    OF - Director → CIF 0
parent relation
Company in focus

NOMPHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
96090 - Other Service Activities N.e.c.
Brief company account
Property, Plant & Equipment
355 GBP2024-01-31
433 GBP2023-01-31
Fixed Assets
355 GBP2024-01-31
433 GBP2023-01-31
Total Inventories
2,580 GBP2023-01-31
Debtors
14,271 GBP2024-01-31
Cash at bank and in hand
2,182 GBP2024-01-31
30,036 GBP2023-01-31
Current Assets
16,453 GBP2024-01-31
32,616 GBP2023-01-31
Net Current Assets/Liabilities
16,453 GBP2024-01-31
-458 GBP2023-01-31
Total Assets Less Current Liabilities
16,808 GBP2024-01-31
-25 GBP2023-01-31
Net Assets/Liabilities
-32,908 GBP2024-01-31
-40,116 GBP2023-01-31
Equity
Called up share capital
100 GBP2024-01-31
100 GBP2023-01-31
Retained earnings (accumulated losses)
-33,008 GBP2024-01-31
-40,216 GBP2023-01-31
Equity
-32,908 GBP2024-01-31
-40,116 GBP2023-01-31
Average Number of Employees
22023-02-01 ~ 2024-01-31
02022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
433 GBP2024-01-31
433 GBP2023-02-01
Property, Plant & Equipment - Gross Cost
433 GBP2024-01-31
433 GBP2023-02-01
Property, Plant & Equipment - Increase or decrease in depreciation and impairment
Tools/Equipment for furniture and fittings
78 GBP2023-02-01 ~ 2024-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
78 GBP2023-02-01 ~ 2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
78 GBP2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
78 GBP2024-01-31
Property, Plant & Equipment
Tools/Equipment for furniture and fittings
355 GBP2024-01-31
Finished Goods/Goods for Resale
2,580 GBP2023-01-31
Trade Debtors/Trade Receivables
14,271 GBP2024-01-31
Trade Creditors/Trade Payables
Amounts falling due within one year
16,244 GBP2023-01-31
Loans received from directors
Amounts falling due within one year
14,244 GBP2023-01-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
2,586 GBP2023-01-31
Bank Borrowings/Overdrafts
Amounts falling due after one year
31,369 GBP2024-01-31
40,091 GBP2023-01-31
Other Creditors
Amounts falling due after one year
18,347 GBP2024-01-31
  • NOMPHARMA LIMITED
    Info
    Registered number 11764276
    Biocity Nottingham Innovation Building Room 202, Pennyfoot Street, Nottingham NG1 1GF
    Private Limited Company incorporated on 2019-01-14 (6 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-12
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.